Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Metabolic Acidosis

In brief

This is a multicenter, double-blind, placebo-controlled, parallel-design study. The study will enroll approximately 210 adult male and female subjects with stage 3 or 4 chronic kidney disease and metabolic acidosis. The study dosing (TRC101 or placebo) will continue for 12 weeks once daily. The maximum study duration is anticipated to be up to 16 weeks.

Key facts

Study ID

NCT03317444

Run by

Tricida, Inc.

People needed

217

Starts

2017-09-26

Expected to finish

2018-05-15

Last updated by the study team

2021-04-26

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Investigative Site 55 — Phoenix, Arizona, United States
• Investigative Site 56 — Chula Vista, California, United States
• Investigative Site 91 — Los Angeles, California, United States
• Investigative Site 59 — Hialeah, Florida, United States
• Investigative Site 54 — Hollywood, Florida, United States
• Investigative Site 93 — Hollywood, Florida, United States
• Investigative Site 92 — Lauderdale Lakes, Florida, United States
• Investigative Site 51 — Tampa, Florida, United States
• Investigative Site 57 — Winter Park, Florida, United States
• Investigative Site 95 — Atlanta, Georgia, United States
• Investigative Site 53 — Shreveport, Louisiana, United States
• Investigative Site 58 — Flushing, New York, United States
• Investigative Site 52 — San Antonio, Texas, United States
• Investigative Site 11 — Sofia, Bulgaria
• Investigative Site 21 — Zagreb, Croatia
• Investigative Site 31 — Tbilisi, Georgia
• Investigative Site 32 — Tbilisi, Georgia
• Investigative Site 33 — Tbilisi, Georgia
• Investigative Site 34 — Tbilisi, Georgia
• Investigative Site 35 — Tbilisi, Georgia
• Investigative Site 36 — Tbilisi, Georgia
• Investigative Site 37 — Tbilisi, Georgia
• Investigative Site 43 — Baja, Hungary
• Investigative Site 48 — Balatonfüred, Hungary
• Investigative Site 41 — Budapest, Hungary

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.